Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage

ObjectiveTo explore the relationship of a new PET image parameter, 18F-fluorodeoxyglucose (18F-FDG) uptake heterogeneity assessed by texture analysis, with maximum standardized uptake value (SUVmax) and tumor TNM staging. Materials and methodsForty consecutive patients with esophageal squamous cell carcinoma were enrolled. All patients underwent whole-body preoperative 18F-FDG PET/CT. Heterogeneity of intratumoral 18F-FDG uptake was assessed on the basis of the textural features (entropy and energy) of the three-dimensional images using MATLAB software. The correlations between the textural parameters and SUVmax, histological grade, tumor location, and TNM stage were analyzed. ResultsTumors with higher SUVmax were seen to be more heterogenous on 18F-FDG uptake. Significant correlations were observed between T stage and SUVmax (rs=0.390, P=0.013), entropy (rs=0.693, P<0.001), and energy (rs=−0.469, P=0.002). Correlations were also found between SUVmax, entropy, energy, and N stage (rs=0.326, P=0.04; rs=0.501, P=0.001; rs=−0.413, P=0.008). The American Joint Committee on Cancer stage correlated significantly with all metabolic parameters. The receiver-operating characteristic curve demonstrated an entropy of 4.699 as the optimal cutoff point for detecting tumors above stage IIb with an areas under the ROC curve of 0.789 (P<0.001). ConclusionThis study provides initial evidence for the relationship between the new parameter of tumor uptake heterogeneity and the commonly used simplistic parameter of SUV and tumor stage. Our findings suggest a complementary role of these parameters in the staging and prognosis of esophageal squamous cell carcinoma.

[1]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[2]  C Clifton Ling,et al.  Dependence of FDG uptake on tumor microenvironment. , 2005, International journal of radiation oncology, biology, physics.

[3]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[4]  K. Miles,et al.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.

[5]  K. Miles,et al.  Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.

[6]  Shu-qi Wu,et al.  Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis , 2009, European journal of gastroenterology & hepatology.

[7]  Yi-Jen Chen,et al.  Impact of the number of resected and involved lymph nodes on esophageal cancer survival , 2009, Journal of surgical oncology.

[8]  John Dickson,et al.  PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Philippe Lambin,et al.  Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Florent Tixier,et al.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  M. Blake,et al.  Applications of PET-CT in patients with esophageal cancer. , 2012, Diagnostic and interventional radiology.

[12]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[13]  Geoff J M Parker,et al.  Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2007, Clinical Cancer Research.

[14]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[15]  Drew A. Torigian,et al.  Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  H. Mak,et al.  Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification , 2010, Nuclear medicine communications.

[17]  Ronald Boellaard,et al.  Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Finbarr O'Sullivan,et al.  A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data. , 2003, Biostatistics.

[19]  J. Bradley,et al.  Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Jinming Yu,et al.  Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[21]  F O'Sullivan,et al.  Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. , 2005, Biostatistics.

[22]  Federico Turkheimer,et al.  Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future , 2012, Molecular Imaging and Biology.

[23]  Balaji Ganeshan,et al.  Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[24]  Zheng Fu,et al.  Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study. , 2009, International journal of radiation oncology, biology, physics.

[25]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[26]  Eugene H. Blackstone,et al.  7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction , 2010, Annals of Surgical Oncology.

[27]  Siewert,et al.  Multimodality Therapy for Esophageal Cancer. , 1996, The oncologist.

[28]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.